This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Anne Bruckner: Innovator in Pharmaceutical Chemistry
Introduction
Anne Bruckner is a notable inventor based in the County of Kent, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work at Pfizer Corporation. Her dedication to research and development has led to the creation of valuable patents that enhance medical science.
Latest Patents
Anne Bruckner holds a patent for the compound (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine. This invention relates to a process for the preparation of this compound, including intermediates and new formulations suitable for pharmaceutical use. The patent highlights the zwitterion monohydrate of the compound, which has potential applications in medicine.
Career Highlights
Throughout her career, Anne has demonstrated a strong commitment to advancing pharmaceutical research. Her work at Pfizer Corporation has positioned her as a key player in the development of innovative therapeutic solutions. With her expertise, she has contributed to the company's mission of improving health outcomes through scientific discovery.
Collaborations
Anne Bruckner has collaborated with esteemed colleagues, including Paul Vincent Fish and Michael Butters. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research conducted at Pfizer Corporation.
Conclusion
Anne Bruckner's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. Her patent and collaborative efforts reflect her commitment to advancing medical science and improving patient care.